Correlation Between Curis and Benitec Biopharma

Can any of the company-specific risk be diversified away by investing in both Curis and Benitec Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Curis and Benitec Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Curis Inc and Benitec Biopharma Ltd, you can compare the effects of market volatilities on Curis and Benitec Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Curis with a short position of Benitec Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Curis and Benitec Biopharma.

Diversification Opportunities for Curis and Benitec Biopharma

-0.6

Correlation Coefficient

Curis  Benitec Biopharma

Excellent diversification

The 3 months correlation between Curis and Benitec is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Curis Inc and Benitec Biopharma Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Benitec Biopharma and Curis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Curis Inc are associated (or correlated) with Benitec Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Benitec Biopharma has no effect on the direction of Curis i.e., Curis and Benitec Biopharma go up and down completely randomly.

Pair Corralation between Curis and Benitec Biopharma

Given the investment horizon of 90 days Curis Inc is expected to under-perform the Benitec Biopharma. In addition to that, Curis is 1.31 times more volatile than Benitec Biopharma Ltd. It trades about -0.04 of its total potential returns per unit of risk. Benitec Biopharma Ltd is currently generating about 0.05 per unit of volatility. If you would invest  1,251  in Benitec Biopharma Ltd on December 28, 2024 and sell it today you would earn a total of  92.00  from holding Benitec Biopharma Ltd or generate 7.35% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	98.36%
Values	Daily Returns

Curis Inc  vs.  Benitec Biopharma Ltd

Curis Inc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Curis Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Benitec Biopharma

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Benitec Biopharma Ltd are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, Benitec Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Curis and Benitec Biopharma

The main advantage of trading using opposite Curis and Benitec Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Curis position performs unexpectedly, Benitec Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Benitec Biopharma will offset losses from the drop in Benitec Biopharma's long position.

The idea behind Curis Inc and Benitec Biopharma Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.